Filing Details

Accession Number:
0001144204-14-016959
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-20 20:44:53
Reporting Period:
2014-03-19
Filing Date:
2014-03-20
Accepted Time:
2014-03-20 20:44:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Ani Pharmaceuticals Inc ANIP Pharmaceutical Preparations (2834) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1109507 Meridian Venture Partners Ii Lp 259 N. Radnor-Chester Road
Suite 130
Radnor PA 19087
No No Yes No
1579672 Jr E. Robert Brown C/O Ani Pharmaceuticals, Inc
210 Main Street West
Baudette MN 56623
Yes No No No
1580169 Meridian Venture Partners Ii, Co. 259 N. Radnor-Chester Road
Suite 130
Radnor PA 19087
No No Yes No
1580170 Meridian Venture Partners Ii Gp, L.p. 259 N. Radnor-Chester Road
Suite 130
Radnor PA 19087
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-19 10,171 $32.38 2,661,310 No 4 S Direct
Common Stock Disposition 2014-03-19 751 $33.36 2,660,559 No 4 S Direct
Common Stock Disposition 2014-03-20 10,000 $31.76 2,650,559 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $33.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
  3. Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the Issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.50 to $32.31 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale